Formulation: A neat solid
Formal Name: 2-[(2R)-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methyl]-2-methyl-1-piperazinyl]-4-methoxy-6-benzothiazolecarboxylic acid
Purity: ≥98%
Formula Markup: C27H26Cl2N4O4S
Formula Weight: 573,5
Shelf life (days): 730
CAS Number: 2226133-29-3
Notes: HPG1860 is a farnesoid X receptor (FXR) agonist.{72454} It induces luminescence in a reporter assay using HEK293T cells expressing human FXR (EC50 = 18 nM). In vivo, HPG1860 (1, 3, or 10 mg/kg per day) decreases the serum levels of alanine transaminase (ALT) and total cholesterol, as well as hepatic inflammation, fat levels, and fibrosis, in a mouse model of non-alcoholic steatohepatitis (NASH) induced by a high-fat diet and carbon tetrachloride (CCl4).